NEWS
Renalytix and Steno Diabetes Center Announce Precision Medicine Collaboration Marking First Expansion for KidneyIntelX Platform Beyond US
Renalytix has announced a collaboration with the Steno Diabetes Center Copenhagen to implement its KidneyIntelX platform in Europe, marking the first expansion outside the US. This partnership aims to enhance the clinical management of diabetes and chronic kidney disease (DKD) through precision medicine. Initial steps involve integrating KidneyIntelX into Steno's laboratory workflows, educating clinicians and patients, and leveraging electronic health records for risk-based care management. The collaboration will also focus on CE marking requirements, clinical utility data, and cost-effectiveness analysis, thus paving the way for future product developments.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
Spread kindness and love. Life is short. Don’t let greed eat you.
1170Followers
73Following
8192Visitors
Follow